Net Cash Provided by (Used in) Financing Activities of BIOXYTRAN, INC from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOXYTRAN, INC quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
  • BIOXYTRAN, INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $166,532, a 67% increase year-over-year.
  • BIOXYTRAN, INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $63,000, a 89% decline from 2023.
  • BIOXYTRAN, INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $550,361, a 73% decline from 2022.
  • BIOXYTRAN, INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2,058,960, a 17% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIOXYTRAN, INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $166,532 +$67,032 +67% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $99,500 +$49,500 +99% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $50,000 -$1,330,960 -96% 01 Jan 2023 31 Mar 2023 10-Q 19 Apr 2024 2024 Q1
Q1 2022 $1,380,960 +$930,960 +207% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $450,000 +$418,948 +1349% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022 2022 Q1
Q1 2020 $31,052 -$191,198 -86% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $222,250 +$222,650 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q1 2018 $400 01 Jan 2018 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q1 2016 $25,000 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q1 2014 $4,050 -$12,116 -150% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q1 2013 $8,066 -$3,437 -30% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q1 2012 $11,503 -$110,110 -91% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q1 2011 $121,613 01 Jan 2011 31 Mar 2011 10-Q/A 22 Jan 2013 2012 Q1

BIOXYTRAN, INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $63,000 -$487,361 -89% 01 Jan 2024 31 Dec 2024 10-K 03 Apr 2025 2024 FY
2023 $550,361 -$1,508,599 -73% 01 Jan 2023 31 Dec 2023 10-K 03 Apr 2025 2024 FY
2022 $2,058,960 +$293,960 +17% 01 Jan 2022 31 Dec 2022 10-K/A 13 Jan 2025 2023 FY
2021 $1,765,000 +$783,948 +80% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $981,052 +$416,802 +74% 01 Jan 2020 31 Dec 2020 10-K 11 Apr 2022 2021 FY
2019 $564,250 +$342,045 +154% 01 Jan 2019 31 Dec 2019 10-K 09 Apr 2021 2020 FY
2018 $222,205 +$199,505 +879% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2020 2019 FY
2017 $22,700 -$27,300 -55% 01 Jan 2017 31 Dec 2017 10-K 02 Apr 2018 2017 FY
2016 $50,000 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2014 $1,800 -$91,393 -98% 01 Jan 2014 31 Dec 2014 10-K 20 Sep 2016 2015 FY
2013 $93,193 +$38,443 +70% 01 Jan 2013 31 Dec 2013 10-K 10 Apr 2015 2014 FY
2012 $54,750 -$485,783 -90% 01 Jan 2012 31 Dec 2012 10-K 14 Apr 2014 2013 FY
2011 $540,533 +$401,501 +289% 01 Jan 2011 31 Dec 2011 10-K 15 Apr 2013 2012 FY
2010 $139,032 01 Jan 2010 31 Dec 2010 10-K/A 31 Dec 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.